Brian Corvese's Insider Trades & SAST Disclosures
Brian Corvese's most recent trade in MiNK Therapeutics Inc was a trade of 2,033 Common Stock done at an average price of $8.8 . Disclosure was reported to the exchange on March 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Brian Corvese.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MiNK Therapeutics Inc | Brian J. Corvese | Director | Grant, award, or other acquisition of securities at price $ 8.79 per share. | 03 Mar 2025 | 2,033 | 44,657 | - | 8.8 | 17,870 | Common Stock |
| MiNK Therapeutics Inc | Brian J. Corvese | Director | Grant, award, or other acquisition of securities at price $ 0.73 per share. | 01 Dec 2024 | 24,400 | 426,283 | - | 0.7 | 17,812 | Common Stock |
| MiNK Therapeutics Inc | Brian J. Corvese | Director | Grant, award, or other acquisition of securities at price $ 0.82 per share. | 03 Sep 2024 | 21,802 | 405,296 | - | 0.8 | 17,878 | Common Stock |
| Agenus Inc | Brian J. Corvese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 750 | 750 | - | - | Stock Option | |
| MiNK Therapeutics Inc | Brian J. Corvese | Director | Grant, award, or other acquisition of securities at price $ 0.99 per share. | 03 Jun 2024 | 17,967 | 383,494 | - | 1.0 | 17,787 | Common Stock |
| MiNK Therapeutics Inc | Brian J. Corvese | Director | Grant, award, or other acquisition of securities at price $ 0.95 per share. | 01 Mar 2024 | 18,816 | 365,527 | - | 0.9 | 17,875 | Common Stock |
| Agenus Inc | Brian J. Corvese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 15,000 | 15,000 | - | - | Stock Option | |
| MiNK Therapeutics Inc | Corvese J. Brian | Director | Grant, award, or other acquisition of securities at price $ 1.04 per share. | 01 Dec 2023 | 17,188 | 346,711 | - | 1.0 | 17,876 | Common Stock |
| MiNK Therapeutics Inc | Brian J. Corvese | Director | Grant, award, or other acquisition of securities at price $ 2.09 per share. | 01 Mar 2023 | 8,553 | 307,348 | - | 2.1 | 17,876 | Common Stock |
| MiNK Therapeutics Inc | Brian J. Corvese | Director | Grant, award, or other acquisition of securities at price $ 2.61 per share. | 01 Dec 2022 | 6,849 | 298,795 | - | 2.6 | 17,876 | Common Stock |
| MiNK Therapeutics Inc | Brian J. Corvese | Director | Grant, award, or other acquisition of securities at price $ 2.62 per share. | 15 Sep 2022 | 13,646 | 13,646 | - | 2.6 | 35,753 | Common Stock |
| MiNK Therapeutics Inc | Brian J. Corvese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Agenus Inc | Brian J. Corvese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Agenus Inc | Brian J. Corvese | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2021 | 22,471 | 92,085 (0%) | 0% | - | Common Stock | |
| Agenus Inc | Brian J. Corvese | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2021 | 16,000 | 16,000 | - | - | Restricted Stock Unit | |
| Agenus Inc | Brian J. Corvese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 100,000 | 100,000 | - | - | Stock Option | |
| Agenus Inc | Brian Corvese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2020 | 100,000 | 100,000 | - | - | Stock Option (Right to buy) | |
| Agenus Inc | Brian Corvese | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jun 2020 | 21,118 | 0 | - | - | Restricted Stock Unit | |
| Agenus Inc | Brian Corvese | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jun 2020 | 21,118 | 69,614 (0%) | 0% | - | Common Stock | |
| Agenus Inc | Brian Corvese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 22,471 | 49,589 | - | - | Restricted Stock Unit | |
| Agenus Inc | Brian Corvese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 2,500 | 2,500 | - | - | Stock Option (Right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges